85 related articles for article (PubMed ID: 16905191)
1. Kaposi's sarcoma-associated herpes virus complement control protein: KCP--complement inhibition and more.
Mark L; Spiller OB; Villoutreix BO; Blom AM
Mol Immunol; 2007 Jan; 44(1-3):11-22. PubMed ID: 16905191
[TBL] [Abstract][Full Text] [Related]
2. The Kaposi's sarcoma-associated herpesvirus complement control protein (KCP) binds to heparin and cell surfaces via positively charged amino acids in CCP1-2.
Mark L; Lee WH; Spiller OB; Villoutreix BO; Blom AM
Mol Immunol; 2006 Apr; 43(10):1665-75. PubMed ID: 16442624
[TBL] [Abstract][Full Text] [Related]
3. Strategies developed by bacteria and virus for protection from the human complement system.
Blom AM
Scand J Clin Lab Invest; 2004; 64(5):479-96. PubMed ID: 15276914
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding.
Spiller OB; Mark L; Blue CE; Proctor DG; Aitken JA; Blom AM; Blackbourn DJ
J Virol; 2006 Apr; 80(8):4068-78. PubMed ID: 16571823
[TBL] [Abstract][Full Text] [Related]
5. Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies.
Mark L; Proctor DG; Blackbourn DJ; Blom AM; Spiller OB
Immunology; 2008 Feb; 123(2):228-38. PubMed ID: 17764451
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against Kaposi sarcoma-associated herpes virus (KSHV) complement control protein (KCP) in infected individuals.
Okroj M; Spiller OB; Korodi Z; Tedeschi R; Dillner J; Blom AM
Vaccine; 2007 Nov; 25(48):8102-9. PubMed ID: 17964697
[TBL] [Abstract][Full Text] [Related]
7. Cloning and expression of a functionally active truncated N-glycosylated KSHV ORF4/KCP/kaposica in the methylotrophic yeast Pichia pastoris.
Gomes Pereira NA; Juliano MA; Carmona AK; Sturrock ED; Kotwal GJ
Ann N Y Acad Sci; 2005 Nov; 1056():388-404. PubMed ID: 16387704
[TBL] [Abstract][Full Text] [Related]
8. The Kaposi's sarcoma-associated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system.
Mark L; Lee WH; Spiller OB; Proctor D; Blackbourn DJ; Villoutreix BO; Blom AM
J Biol Chem; 2004 Oct; 279(43):45093-101. PubMed ID: 15304516
[TBL] [Abstract][Full Text] [Related]
9. Influence of electrostatics on the complement regulatory functions of Kaposica, the complement inhibitor of Kaposi's sarcoma-associated herpesvirus.
Pyaram K; Kieslich CA; Yadav VN; Morikis D; Sahu A
J Immunol; 2010 Feb; 184(4):1956-67. PubMed ID: 20089702
[TBL] [Abstract][Full Text] [Related]
10. Functional activity of the complement regulator encoded by Kaposi's sarcoma-associated herpesvirus.
Spiller OB; Blackbourn DJ; Mark L; Proctor DG; Blom AM
J Biol Chem; 2003 Mar; 278(11):9283-9. PubMed ID: 12645526
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of the rhesus rhadinovirus (RRV) ORF4 gene and the RRV complement control protein it encodes.
Mark L; Spiller OB; Okroj M; Chanas S; Aitken JA; Wong SW; Damania B; Blom AM; Blackbourn DJ
J Virol; 2007 Apr; 81(8):4166-76. PubMed ID: 17287274
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the complement inhibitory function of rhesus rhadinovirus complement control protein (RCP).
Okroj M; Mark L; Stokowska A; Wong SW; Rose N; Blackbourn DJ; Villoutreix BO; Spiller OB; Blom AM
J Biol Chem; 2009 Jan; 284(1):505-514. PubMed ID: 18990693
[TBL] [Abstract][Full Text] [Related]
13. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
14. Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression.
Lefort S; Soucy-Faulkner A; Grandvaux N; Flamand L
J Virol; 2007 Oct; 81(20):10950-60. PubMed ID: 17652396
[TBL] [Abstract][Full Text] [Related]
15. Humanized recombinant vaccinia virus complement control protein (hrVCP) with three amino acid changes, H98Y, E102K, and E120K creating an additional putative heparin binding site, is 100-fold more active than rVCP in blocking both classical and alternative complement pathways.
Ghebremariam YT; Odunuga OO; Janse K; Kotwal GJ
Ann N Y Acad Sci; 2005 Nov; 1056():113-22. PubMed ID: 16387681
[TBL] [Abstract][Full Text] [Related]
16. Immune evasion by Kaposi's sarcoma-associated herpesvirus.
Coscoy L
Nat Rev Immunol; 2007 May; 7(5):391-401. PubMed ID: 17457345
[TBL] [Abstract][Full Text] [Related]
17. Viral complement regulators: the expert mimicking swindlers.
Ahmad M; Pyaram K; Mullick J; Sahu A
Indian J Biochem Biophys; 2007 Oct; 44(5):331-43. PubMed ID: 18341208
[TBL] [Abstract][Full Text] [Related]
18. Identification of functional domains in kaposica, the complement control protein homolog of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8).
Mullick J; Singh AK; Panse Y; Yadav V; Bernet J; Sahu A
J Virol; 2005 May; 79(9):5850-6. PubMed ID: 15827200
[TBL] [Abstract][Full Text] [Related]
19. Lack of heparan sulfate expression in B-cell lines: implications for Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 infections.
Jarousse N; Chandran B; Coscoy L
J Virol; 2008 Dec; 82(24):12591-7. PubMed ID: 18842731
[TBL] [Abstract][Full Text] [Related]
20. Role of the C3b-binding site on C4b-binding protein in regulating classical pathway C5 convertase.
Rawal N; Pangburn MK
Mol Immunol; 2007 Feb; 44(6):1105-14. PubMed ID: 16979240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
